These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7879985)

  • 1. Pharmacokinetics and short-term clinicopathologic changes after intravenous administration of a high dose of methimazole in dogs.
    Vail DM; Elfarra AA; Panciera DL; Hutson PR
    Am J Vet Res; 1994 Nov; 55(11):1597-601. PubMed ID: 7879985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on doses of methimazole (MMI) and its administration regimen on broiler metabolism.
    Rosebrough RW; Russell BA; McMurtry JP
    Comp Biochem Physiol A Mol Integr Physiol; 2006 Jan; 143(1):35-41. PubMed ID: 16337159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous and oral methimazole following single- and multiple-dose administration in normal cats.
    Trepanier LA; Peterson ME; Aucoin DP
    J Vet Pharmacol Ther; 1991 Dec; 14(4):367-73. PubMed ID: 1774813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phenobarbital treatment on serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs.
    Gaskill CL; Burton SA; Gelens HC; Ihle SL; Miller JB; Shaw DH; Brimacombe MB; Cribb AE
    J Am Vet Med Assoc; 1999 Aug; 215(4):489-96. PubMed ID: 10461631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of short term triiodothyronine administration to broiler chickens fed methimazole.
    Rosebrough RW; Russell BA; Richards MP
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Jul; 150(1):72-8. PubMed ID: 19272462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-thyroid drug methimazole induces neovascularization in the neonatal rat analogous to ROP.
    Mookadam M; Leske DA; Fautsch MP; Lanier WL; Holmes JM
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4145-50. PubMed ID: 15505068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ibuprofen after intravenous and oral administration and assessment of safety of administration to healthy foals.
    Breuhaus BA; DeGraves FJ; Honore EK; Papich MG
    Am J Vet Res; 1999 Sep; 60(9):1066-73. PubMed ID: 10490073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculation of maximal removal rate of indocyanine green to measure hepatic functional mass in dogs by use of the nine-hour method.
    Furuhama K; Goi S; Kawarabayashi K; Maru C; Inage F
    Am J Vet Res; 1996 Jun; 57(6):803-6. PubMed ID: 8725803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term oral administration of levothyroxine sodium on serum thyroid hormone concentrations, clinicopathologic variables, and echocardiographic measurements in healthy adult horses.
    Frank N; Buchanan BR; Elliott SB
    Am J Vet Res; 2008 Jan; 69(1):68-75. PubMed ID: 18167089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of topical methimazole for the treatment of melasma. Transdermal absorption, the effect on thyroid function and cutaneous adverse effects.
    Kasraee B; Safaee Ardekani GH; Parhizgar A; Handjani F; Omrani GR; Samani M; Nikbakhsh M; Tanideh N; Eshraghian A; Sorg O; Saurat JH
    Skin Pharmacol Physiol; 2008; 21(6):300-5. PubMed ID: 18667842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone pharmacokinetics in clinically normal dogs during low- and high-dose dexamethasone suppression testing.
    Greco DS; Brown SA; Gauze JJ; Weise DW; Buck JM
    Am J Vet Res; 1993 Apr; 54(4):580-5. PubMed ID: 8387253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of d,l-ethionine as a mechanism for pancreatic islet regeneration in dogs.
    Govendir M; Canfield PJ; Emslie DR; Watson AD; Church DB
    Aust Vet J; 2002; 80(1-2):75-82; discussion 82. PubMed ID: 12180885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of nephrotoxicosis associated with a short-term saline solution diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989).
    Ogilvie GK; Straw RC; Powers BE; Cooper MF; Withrow SJ
    J Am Vet Med Assoc; 1991 Sep; 199(5):613-6. PubMed ID: 1787122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model.
    Huang Z; Raychowdhury MK; Waxman DJ
    Cancer Gene Ther; 2000 Jul; 7(7):1034-42. PubMed ID: 10917206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of L-thyroxine after its oral administration in dogs.
    Nachreiner RF; Refsal KR; Ravis WR; Hauptman J; Rosser EJ; Pedersoli WM
    Am J Vet Res; 1993 Dec; 54(12):2091-8. PubMed ID: 8116944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cisplatin-induced nephrotoxicosis in dogs, using hypertonic saline solution as the vehicle of administration.
    Forrester SD; Fallin EA; Saunders GK; Kenny JE
    Am J Vet Res; 1993 Dec; 54(12):2175-8. PubMed ID: 8116956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.